<img alt="" height="1" width="1" />Neurocrine Biosciences Reports First Quarter 2010 ResultsPR Newswire (press release)... affinity and selective antagonists for the CRF1 receptor that are currently in clinical development for mood disorders and irritable bowel syndrome. ...<nobr>and more »</nobr> |